DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 09 · Volume 72 · 1994 DOI: 10.1055/s-008-40508

Review Article

330
Boneu, B: Low Molecular Weight Heparin Therapy: Is Monitoring Needed?

Original Article

335
Moor, Elisabeth; Hamsten, Anders; Blombäck, Margareta; Herzfeld, Istvan; Wiman, Björn; Rydén, Lars: Haemostatic Factors and Inhibitors and Coronary Artery Bypass Grafting: Preoperative Alterations and Relations to Graft Occlusion
343
Alessandri, Cesare; Basili, Stefania; Violi, Francesco; Ferroni, Patrizia; Gazzaniga, Pier Paolo; Cordova, Corrado; C.O.B.H. Group: Hypercoagulability State in Patients with Chronic Obstructive Pulmonary Disease
347
Azar, Aida J; Deckers, Jaap W; Rosendaal, Frits R; van Bergen, Paul F M M; van der Meer, Felix J M; Jonker, Jan J C; Briëf, Ernest: Assessment of Therapeutic Quality Control in a Long-Term Anticoagulant Trial in Post-Myocardial Infarction Patients
352
De Stefano, V; Leone, G; Mastrangelo, S; Tripodi, A; Rodeghiero, F; Castaman, G; Barbui, T; Finazzi, G; Bizzi, B; Mannucci, P M: Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S
359
Varon, D; Schulman, S; Dardik, R; Barzilai, A; Bashari, D; Martinowitz, U: High Versus Ultra-high Purity Factor VIII Concentrate Therapy: Prospective Evaluation of Immunological and Clinical Parameters in HIV Seronegative and Seropositive Hemophiliacs
363
Vijaya Mohan Rao, L; Zivelin, Ariella; Iturbe, Ignacio; Rapaport, Samuel I: Antibody-Induced Acute Factor X Deficiency: Clinical Manifestations and Properties of the Antibody
372
Meissner, Mark H; Manzo, Richard A; Bergelin, Robert O; Eugene Strandness, D: Venous Diameter and Compliance after Deep Venous Thrombosis
377
Biemond, Bart J; Levi, Marcel; Nurmohanned, Michael T; Büller, Harry R; ten Cate, Jan W: Additive Effect of the Combined Administration of Low Molecular Weight Heparin and Recombinant Hirudin on Thrombus Growth in a Rabbit Jugular Vein Thrombosis Model
381
Berry, Christopher N; Girardot, Christine; Lecoffreo, Catherine; Lunven, Catherine: Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin
387
Gallistl, Siegfried; Muntean, Wolfgang: Thrombin-Hirudin Complex Formation, Thrombin-Antithrombin III Complex Formation, and Thrombin Generation after Intrinsic Activation of Plasma
393
Yamazaki, Masahide; Asakura, Hidesaku; Aoshima, Keiji; Saito, Masanori; Jokaji, Hiroshi; Uotani, Chika; Kumabashiri, Ichir; Morishita, Eriko; Ikeda, Takayuki; Matsuda, Tamotsu: Effects of DX-9065a, an Orally Active, Newly Synthesized and Specific Inhibitor of Factor Xa, against Experimental Disseminated Intravascular Coagulation in Rats
397
von dem Borne, Peter A Kr; Koppelman, Stefan J; Bouma, Bonno N; Meijers, Joost C M: Surface Independent Factor XI Activation by Thrombin in the Presence of High Molecular Weight Kininogen
403
Schulman, S; Varon, D; Keller, N; Gitel, S; Martinowitz, U: Monoclonal Purified F VIII for Continuous Infusion: Stability, Microbiological Safety and Clinical Experience
408
Meijer-Huizinga, Fenny; Mertens, Koen; van Mourik, Jan A: Isolation and Characterization of Single-Chain Protein S
415
Arnljots, Björn; Bergqvist, David; Dahlbäck, Björn: Inhibition of Microarterial Thrombosis by Activated Protein C in a Rabbit Model
421
Ono, Mayumi; Nawa, Katsuhiko; Marumoto, Yasumasa: Antithrombotic Effects of Recombinant Human Soluble Thrombomodulin in a Rat Model of Vascular Shunt Thrombosis
426
Kitchen, S; Walker, I D; Woods, T A L; Preston, F E: Thromboplastin Related Differences in the Determination of International Normalised Ratio: A Cause for Concern?
430
Mola, Marco; Mannucci, Pier Mannuccio; Pini, Marlo; Prandoni, Paolo; Gurewich, Victor: A Pilot Study of Pro-Urokinase in the Treatment of Deep Vein Thrombosis
434
Bruckert, E; Ankri, A; Glral, P; Turpin, G: Relation between Plasminogen Activator Inhibitor-1 and Hepatic Enzyme Concentrations in Hyperlipidemic Patients
438
Lu, He; Du Buit, Charles; Soria, Jeannette; Touchot, Bernard; Chollet, Bernard; Commin, Pierre L; Conseiller, Christian; Echter, Ernest; Soria, Claudine: Postoperative Hemostasis and Fibrinolysis in Patients Undergoing Cardiopulmonary Bypass with or without Aprotinin Therapy
444
Simsek, S; Admiraal, L G; Modderman, P W; van der Schoot, C E; von dem Borne, A E G Kr: Identification of a Homozygous Single Base Pair Deletion in the Gene Coding for the Human Platelet Glycoprotein Ibα Causing Bernard-Soulier Syndrome
450
Maugeri, Norma; Evangelista, Virgilio; Celardo, Antonio; Dell’Elba, Giuseppe; Martelli, Nicola; Piccardoni, Paola; de Gaetano, Glovanni; Cerletti, Chiara: Polymorphonuclear Leukocyte-Platelet Interaction: Role of P-Selectin in Thromboxane B2 and Leukotriene C4 Cooperative Synthesis
457
Hemmer, Christoph J; Bierhaus, A; Riedesel, J v; Gabat, S; Liliensiek, B; Pitronik, P; Lin, J; Grauer, A; Amiral, J; Ziegler, R; Schieffer, S; Kern, P; Seitz, R; Egbring, R; Dietrich, M; Nawroth, P P: Elevated Thrombomodulin Plasma Levels as a Result of Endothelial Involvement in Plasmodium falciparum Malaria
465
Bangalore, Neelesh; Drohan, William N; Orthner, Carolyn L: High Affinity Binding Sites for Activated Protein C and Protein C on Cultured Human Umbilical Vein Endothelial Cells
477
Markwardt, F: Inventory of Coagulation Inhibitors from Animals Feeding on Blood
481
Simioni, Paolo; Prandoni, Paolo; Girolami, Antonio: Patients with AT III, Protein C or Protein S Defects Show no Associated Hereditary APC-Resistance
482
Bannon, P G; Dawes, J; Dean, R T: Malformin A Prevents IL-1 Induced Endothelial Changes by Inhibition of Protein Synthesis
483
Schoppmann, Axel; Weber, Alfred; Hondl, Felix; Linnau, Yendra: Factor VIII Concentrate: What is “High Purity”?
484
Fabris, Fabrizio; Luzzatto, Guido; Randi, Maria Luigia; Cella, Giuseppe: Beta-Thromboglobulin (βtg) and Platelet Factor 4 (PF4) in Patients with Myeloproliferative Diseases
485
Bellucci, Sylvia: Beta-Thromboglobulin and Platelet Factor 4 in Patients with Myeloproliferative Diseases - Reply
486
Meyer-Luerssen, D: Questions Concerning the New Recommended Mean Normal Prothrombin Time (MNPT) to Calculate the International Normalized Ratio (INR)
487
van den Besselaar, A M H P: Arguments for the Recommended Mean Normal Prothrombin Time to Calculate the International Normalized Ratio - Rebuttal
488
Smith, Michael; Kortmann, Cas: Rebuttal of the Article of Bounameaux et al
489
Bounameaux, H; de Moerloose, P; Perrier, A; Reber, G: Reply to the Rebuttal of Smith and Kortmann

Scientific and Standardization Committee Communications

475
Peake, Ian; Tuddenham, Edward: A Standard Nomenclature for Factor VIII and Factor IX Gene Mutations and Associated Amino Acid Alterations